VIP and vibrio infectious disease: To explore this possibility, the effects of VIP inhibitors or antagonists on cholera toxin-induced intestinal fluid losses in suitable animal models, such as the dog [44] or cat [45] cholera models, are warranted, elevated VIP levels in intestinal venous blood having already been demonstrated in the latter.